sk&f-38393 has been researched along with sk&f 81297 in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (4.76) | 18.7374 |
1990's | 8 (38.10) | 18.2507 |
2000's | 10 (47.62) | 29.6817 |
2010's | 2 (9.52) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brush, CK; Hahn, RA; Holden, KG; Kuo, GY; Ladd, DL; Pfeiffer, FR; Ridley, PT; Sarau, HM; Setler, PE; Tobia, AJ; Wardell, JR; Weinstock, J; Wilson, JW; Yim, NC | 1 |
Gerlach, J; Lublin, H; Peacock, L | 1 |
Drukarch, B; Jongenelen, CA; Langeveld, CH; Stoof, JC; Vermeulen, RJ; Wolters, EC | 1 |
Bergman, J; Rosenzweig-Lipson, S | 1 |
Boldry, RC; Chase, TN; Kask, AM; Papa, SM | 1 |
Bergman, J; Grech, DM; Spealman, RD | 1 |
Andringa, G; Cools, AR; Drukarch, B; Stoof, JC; Vermeulen, RJ | 1 |
Abrahams, BS; Beninger, RJ; Mallet, PE; Rutherford, JD | 1 |
Gorelova, NA; Yang, CR | 1 |
Ainsworth, K; Sharp, T; Smith, SE | 1 |
Nader, MA; Sinnott, RS | 1 |
Andringa, G; Cools, AR; Lubbers, L; van Oosten, RV | 1 |
Andersen, SL; Dumont, NL; Teicher, MH; Thompson, AP | 1 |
Kiehn, L; Mukai, ST; Saleuddin, AS | 1 |
Desai, RI; Katz, JL; Terry, P | 1 |
Berridge, KC; Matell, MS; Wayne Aldridge, J | 1 |
Fan, T; George, SR; Kong, MM; O'dowd, BF; Varghese, G | 1 |
Ariano, MA; Cepeda, C; Hernández-Echeagaray, E; Levine, MS; Lobo, MK; Sibley, DR | 1 |
Bezzina, G; Body, S; Bradshaw, CM; Cheung, TH; Fone, KC; Hampson, CL; Szabadi, E | 1 |
Albericio, F; Canela, EI; Casadó, V; Cortés, A; Franco, R; Gonzalez, S; Lluís, C; Mallol, J; Royo, M; Soriano, A; Vendrell, M | 1 |
Abraham, AD; Lattal, KM; Neve, KA | 1 |
21 other study(ies) available for sk&f-38393 and sk&f 81297
Article | Year |
---|---|
Separation of potent central and renal dopamine agonist activity in substituted 6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepines.
Topics: Animals; Benzazepines; Central Nervous System; Kidney; Rats; Receptors, Dopamine; Structure-Activity Relationship; Vasodilator Agents | 1980 |
Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Cebus; Dopamine Agents; Dyskinesia, Drug-Induced; Ergolines; Female; Grooming; Haloperidol; Hypnotics and Sedatives; Male; Motor Activity; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Substance Withdrawal Syndrome | 1992 |
Dopamine D1 receptor agonists display a different intrinsic activity in rat, monkey and human astrocytes.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Astrocytes; Benzazepines; Brain; Cells, Cultured; Chromans; Cyclic AMP; Dopamine Agonists; Female; Humans; Macaca mulatta; Male; Rats; Rats, Wistar; Stereoisomerism | 1994 |
Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Catalepsy; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Isoquinolines; Male; Receptors, Dopamine D1; Saimiri; Tetrahydroisoquinolines | 1994 |
MK-801 reverses effects of chronic levodopa on D1 and D2 dopamine agonist-induced rotational behavior.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dizocilpine Maleate; Dopamine Agents; Dopamine Agonists; Ergolines; Excitatory Amino Acid Antagonists; Levodopa; Male; Oxidopamine; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Stereotyped Behavior; Sympatholytics | 1995 |
Self-administration of D1 receptor agonists by squirrel monkeys.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benzazepines; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Receptors, Dopamine D1; Saimiri; Self Administration | 1996 |
Dopamine receptor subtypes as targets for the pharmacotherapy of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Benzazepines; Dopamine Agonists; Haplorhini; Levodopa; Motor Activity; Parkinson Disease, Secondary; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1 | 1998 |
Place conditioning with the dopamine D1-like receptor agonist SKF 82958 but not SKF 81297 or SKF 77434.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Conditioning, Operant; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Motor Activity; Rats; Rats, Wistar; Receptors, Dopamine D1 | 1998 |
Dopamine D1/D5 receptor activation modulates a persistent sodium current in rat prefrontal cortical neurons in vitro.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Alkaloids; Animals; Benzazepines; Benzophenanthridines; Cyclic AMP-Dependent Protein Kinases; Dopamine; Dopamine Agonists; Enzyme Inhibitors; In Vitro Techniques; Kinetics; Male; Membrane Potentials; Patch-Clamp Techniques; Phenanthridines; Prefrontal Cortex; Protein Kinase C; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D5; Sodium; Tetrodotoxin | 2000 |
Repeated administration of fluoxetine, desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Apomorphine; Behavior, Animal; Benzazepines; Desipramine; Dopamine Agonists; Fluoxetine; Male; Phenethylamines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Tranylcypromine | 1998 |
Modulation of cocaine's discriminative stimulus effects by dopamine D(1) agonists in rhesus monkeys.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Cocaine; Discrimination Learning; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Macaca mulatta; Male; Receptors, Dopamine D1 | 2001 |
SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals?
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Animals; Antiparkinson Agents; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Male; Motor Activity; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Dopamine D1; Social Environment; Stereotyped Behavior | 2002 |
Transient dopamine synthesis modulation in prefrontal cortex: in vitro studies.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Female; In Vitro Techniques; Male; Prefrontal Cortex; Rats; Rats, Sprague-Dawley | 2004 |
Dopamine stimulates snail albumen gland glycoprotein secretion through the activation of a D1-like receptor.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Exocrine Glands; Fresh Water; Glycoproteins; Phenanthridines; Receptors, Dopamine D1; Reproduction; Signal Transduction; Snails; Tetrahydronaphthalenes | 2004 |
A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Animals; Benzazepines; Cocaine; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Hydrolysis; Male; Mice; Motor Activity; Phosphatidylinositols; Receptors, Dopamine D1; Time Factors | 2005 |
Dopamine D1 activation shortens the duration of phases in stereotyped grooming sequences.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Biological Clocks; Dopamine Agonists; Grooming; Male; Rats; Rats, Inbred F344; Receptors, Dopamine D1; Stereotyped Behavior; Time Factors | 2006 |
Agonist-induced cell surface trafficking of an intracellularly sequestered D1 dopamine receptor homo-oligomer.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amino Acid Substitution; Animals; Apomorphine; Benzazepines; Binding, Competitive; Cell Line; Cell Membrane; Cell Membrane Permeability; Chlorocebus aethiops; COS Cells; Cyclic AMP; Dimerization; Dopamine; Dopamine Agonists; Gene Expression; Humans; Microscopy, Fluorescence; Mutation; Protein Transport; Radioligand Assay; Receptors, Dopamine D1; Transfection | 2006 |
Dopamine reduction of GABA currents in striatal medium-sized spiny neurons is mediated principally by the D(1) receptor subtype.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Corpus Striatum; Dopamine; Mice; Mice, Knockout; Patch-Clamp Techniques; Receptors, Dopamine D1; Receptors, Dopamine D5; Receptors, GABA-A; Reverse Transcriptase Polymerase Chain Reaction; Sulpiride | 2007 |
Evidence for the sensitivity of operant timing behaviour to stimulation of D1 dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benzazepines; Conditioning, Operant; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Haloperidol; Psychometrics; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Time Perception | 2007 |
A hybrid indoloquinolizidine peptide as allosteric modulator of dopamine D1 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Allosteric Regulation; Benzazepines; Cell Line; Cyclic AMP; Drug Partial Agonism; Humans; Ligands; Oligopeptides; Quinolizidines; Radioligand Assay; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2010 |
Activation of D1/5 Dopamine Receptors: A Common Mechanism for Enhancing Extinction of Fear and Reward-Seeking Behaviors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; beta-Arrestins; Cocaine; Conditioning, Classical; Cyclic AMP; Extinction, Psychological; Fear; Male; Mice, Inbred C57BL; Receptors, Dopamine D1; Receptors, Dopamine D5; Reward | 2016 |